Evidence map›Paper›PMID 37767396›Full record

ArticleFrontiers in pharmacology2023

Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex.

Lorenzo Santini, Claudia Duranti, Chiara Palandri, Lucrezia Giammarino, Monica Musumeci, Lucia Carlucci, Chiara Capitani, Rossella Colasurdo, Fabio Recchia, Elisabetta Cerbai and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lorenzo Santini *Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Claudia Duranti *Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, Florence, Italy.
Chiara PalandriDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Lucrezia GiammarinoDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Monica MusumeciDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Lucia CarlucciInstitute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Chiara CapitaniDepartment of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, Florence, Italy.
Rossella ColasurdoDepartment of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, Florence, Italy.
Fabio RecchiaInstitute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Elisabetta CerbaiDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Raffaele Coppini *Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Annarosa Arcangeli *Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, Florence, Italy.
University of Florence · ITScuola Superiore Sant'Anna · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

APDbispecific antibodiescancer therapyIKrQT prolongation

Identifiers

PMID37767396
PMCPMC10520717
OpenAlexW4386638559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.